Ben Goldacre’s biography, net worth, fact, career, awards and life story

Intro British science writer and doctor
A.K.A. Ben Michael Goldacre
Is Journalist 
Science journalist 
Psychiatrist 
Author 
Scientist 
From United Kingdom 
Type Healthcare 
Journalism 
Literature 
Science 
Gender male
Birth 30 April 1974, London
Age: 46 years
Family
Father: Michael Goldacre

Ben Michael Goldacre (born 20 May 1974) is a British physician, academic and science writer. As of March 2015, he is a Senior Clinical Research Fellow at the Centre for Evidence-Based Medicine, part of the University of Oxford’s Nuffield Department of Primary Care Health Sciences. He is a founder of the AllTrials campaign and OpenTrials to require open science practices in clinical trials.
Goldacre is known in particular for his Bad Science column in The Guardian, which he wrote between 2003 and 2011, and is the author of three books: Bad Science (2008), a critique of irrationality and certain forms of alternative medicine; Bad Pharma (2012), an examination of the pharmaceutical industry, its publishing and marketing practices, and its relationship with the medical profession, and I Think You’ll Find It’s a Bit More Complicated Than That, a collection of his journalism. Goldacre frequently delivers free talks about bad science—he describes himself as a “nerd evangelist.”

Early life and education

Goldacre is the son of Michael Goldacre, a professor of public health at the University of Oxford, and Susan Traynor (a.k.a. Noosha Fox) lead singer of 1970s’ pop band Fox, both of whom are Australian. He is the nephew of Robyn Williams, a science journalist, and the great-great-grandson of Sir Henry Parkes, politician and journalist who is considered the father of the Australian Federation. He has two children.

Goldacre was educated at Magdalen College School, Oxford. He studied medicine at Magdalen College, Oxford, where he obtained a first-class Bachelor of Arts honours degree during his preclinical studies in 1995 in Physiological Sciences. He edited the Oxford student magazine, Isis.

Goldacre was a visiting researcher in cognitive neuroscience at the University of Milan, working on fMRI brain scans of language and executive function. Following his studies at the Universities of Oxford and Milan, Goldacre studied clinical medicine at UCL Medical School, qualifying as a medical doctor in 2000 with a Bachelor of Medicine, Bachelor of Surgery (MB, BS) degree. He also received a Master of Arts degree in philosophy from King’s College London in 1997.

Career and research

Scientific career

Goldacre passed the Member of the Royal College of Psychiatrists (MRCPsych) Part II examinations in December 2005 and became a member of the Royal College of Psychiatrists. He was made a research fellow at the Institute of Psychiatry in London in 2008, and a Guardian research fellow at Nuffield College, Oxford, in 2009.

In 2012, Goldacre was appointed a Wellcome Trust Research Fellow in Epidemiology at the London School of Hygiene & Tropical Medicine.

In 2015, Goldacre moved to the Nuffield Department of Primary Care Health Sciences’s Centre for Evidence-Based Medicine, joining a project funded by a grant from the Laura and John Arnold Foundation.

As of 2016, according to Scopus and Google Scholar his most cited articles have been published in NeuroReport, the European Journal of Preventive Cardiology, the British Medical Journal (BMJ), The Lancet, and PLOS ONE.

Bad Science Guardian column and blog

Goldacre is known for his weekly column, “Bad Science,” in the Saturday edition of The Guardian, which he started in 2003 and wrote until November 2011. Devoted to criticism of scientific inaccuracy, health scares and pseudoscience, the column focuses on the media, marketing, problems with the pharmaceutical industry, and its relationship with medical journals and alternative-medicine practitioners.

He has been a particularly hardline critic of the nutritionist Gillian McKeith, anti-immunisation campaigners (particularly followers of Andrew Wakefield such as Melanie Phillips and Jeni Barnett), Brain Gym, bogus positive MRSA swab stories in tabloid newspapers, publication bias, and the makers of the product Penta Water.

While investigating McKeith’s membership of the American Association of Nutritional Consultants, Goldacre purchased a “certified professional membership” on behalf of his late cat, Henrietta, from the same institution for $60.

In February 2007 McKeith agreed to stop using the title “Doctor” in her advertising, following a complaint to the Advertising Standards Authority by a “Bad Science” reader. In an interview with Richard Saunders of the podcast Skeptic Zone, Goldacre said, “Nutritionists are particularly toxic because they are the alternative therapists who, more than any other, misrepresent themselves as being men and women of science.”

In 2008, Matthias Rath, a vitamin entrepreneur, sued Goldacre and The Guardian over three articles, in which Goldacre criticised Rath’s promotion of vitamin pills to AIDS sufferers in South African townships. Rath dropped his action in September 2008 and was ordered to pay initial costs of £220,000 to The Guardian. The paper is seeking full costs of £500,000, and Goldacre has expressed an interest in writing a book about Rath and South Africa, as a chapter on the subject had to be cut from his book while the litigation proceeded. The chapter was reinstated in a later edition of the book, and also published online. Goldacre continues to cite Rath as a proponent of harmful pseudoscience.

Bad Science book, 2008

Goldacre’s first book, Bad Science, was published by Fourth Estate in September 2008. The book contains extended and revised versions of many of his Guardian columns. It was positively reviewed by the British Medical Journal (BMJ) and The Daily Telegraph, and reached the Top 10 bestseller list for Amazon Books. It was nominated for the 2009 Samuel Johnson Prize. In an interview in 2008, Goldacre said that “one of the central themes of my book [Bad Science] is that there are no real differences between the $600 billion pharmaceutical industry and the $50 billion food supplement pill industry.”

Bad Pharma book, 2012

His second book, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, was published in the UK in September 2012 and in the United States and Canada in February 2013. In the book he argues that:

Drugs are tested by the people who manufacture them, in poorly designed trials, on hopelessly small numbers of weird, unrepresentative patients, and analysed using techniques which are flawed by design, in such a way that they exaggerate the benefits of treatments. Unsurprisingly, these trials tend to produce results that favour the manufacturer. When trials throw up results that companies don’t like, they are perfectly entitled to hide them from doctors and patients, so we only ever see a distorted picture of any drug’s true effects. Regulators see most of the trial data, but only from early on in a drug’s life, and even then they don’t give this data to doctors or patients, or even to other parts of government. This distorted evidence is then communicated and applied in a distorted fashion. In their forty years of practice after leaving medical school, doctors hear about what works through ad hoc oral traditions, from sales reps, colleagues or journals. But those colleagues can be in the pay of drug companies – often undisclosed – and the journals are too. And so are the patient groups. And finally, academic papers, which everyone thinks of as objective, are often covertly planned and written by people who work directly for the companies, without disclosure.

Other journalism and writing

Goldacre contributed to The Atheist’s Guide to Christmas (2009), a charity book featuring essays and anecdotes from 42 well-known atheists and apatheists, on the subject of “the power of ideas”. He describes himself as an apatheist. He also wrote the foreword to the reprint edition of Testing Treatments: Better Research for Better Healthcare by Imogen Evans, Hazel Thornton, Iain Chalmers and Paul Glasziou, published by Pinter & Martin in March 2010. He has had several articles published in the British Medical Journal (BMJ) on the MMR vaccine, science journalism, and related topics.

In June 2012, he collaborated with the Behavioural Insights Team of the UK government on a policy paper on the use of randomised controlled trials, and in May 2013, he wrote the foreword to the ‘Official Guidebook’ of the Romney, Hythe and Dymchurch Railway. In March 2014, he worked on a systematic review of the side effects of statins compared with placebos, published in the European Journal of Preventive Cardiology. Although many newspapers that covered the review said that it found that statins have “virtually no side effects”, Goldacre criticized this coverage as inaccurate. For example, he noted that the study relied on data from trial reports, which are likely to be incomplete.

Several of Goldacre’s articles were assembled into the October 2014 release I Think You’ll Find It’s a Bit More Complicated Than That.

Awards and honours

Goldacre has won several awards including:

  • Association of British Science Writers (ABSW) award for Best Feature 2003 for his article “Never mind the facts”.
  • Association of British Science Writers award for Best Feature 2005 for his article “Don’t dumb me down”.
  • Freelance of 2006 at the Medical Journalism Awards.
  • The Committee for Skeptical Inquiry (CSICOP) presented in 2006 the Balles Prize in Critical Thinking award for his column in The Guardian U.K. newspaper, Bad Science Columns include “Dyslexia ‘cure’ fails to pass the tests”, “Bring me a God helmet, and bring it now”, “Kick the habit with wacky wave energy”, “Brain Gym exercises do pupils no favors” and “Magnetic attraction? Shhhh. It’s a secret”
  • The inaugural Statistical Excellence In Journalism Award of the Royal Statistical Society for his article “When the facts get in the way of a story”.
  • The HealthWatch Award from HealthWatch.
  • Honorary Doctor of Science at Heriot-Watt University (June 2009).
  • Honorary Doctor of Science at Loughborough University (July 2010).
  • Goldacre, Ben (11 December 2003). “Never mind the facts”. The Guardian. 
  • Goldacre, Ben (8 September 2005). “Don’t dumb me down”. The Guardian. 
  • “MJA News October/November 2006” (PDF). Medical Journalists Association. 2006. Retrieved 14 August 2008. 
  • “CSI’s Robert P. Balles Award Goes to ‘Guardian ‘Bad Science’ Columnist Ben Goldacre”. Skeptical Inquirer. 31 (5): 13. 2007. 
  • Anon (2007). “2007 Award for statistical excellence in journalism”. rss.org.uk. Royal Statistical Society. Archived from the original on 2012-04-24. Retrieved 14 August 2008. 
  • Goldacre, Ben (1 April 2006). “When the facts get in the way of a story”. The Guardian. 
  • Heriot-Watt University Graduations: Honorary Graduates, hw.ac.uk; accessed 27 July 2015.
  • Loughborough University News and Events: Honorary Graduates, lboro.ac.uk; accessed 27 July 2015.
You May Also Like

David Guetta’s net worth, biography, fact, career, awards and life story

David Guetta Net Worth: David Guetta is a French house producer and DJ who has a net worth of $85 million. Guetta is one of the most well-known DJs in the world, and he is famous for a number of high-profile tracks. While Guetta has been dubbed “the grandfather of EDM,” he has also collaborated with a number of pop musicians to create more mainstream music. David has experienced success around the globe, and he is especially popular in places like the United Kingdom and the United States. It is estimated that David Guetta earns approximately $30 million per year. Early Life: Pierre David Guetta was born on November 7th of 1967 in Paris, France. Raised in a Jewish household with Moroccan roots, Pierre became interested in music from an early age. His older half-brother Bernard Guetta is a renowned French journalist, while his older half-sister is Nathalie Guetta, a French actress. .cnw_key_facts-widget{margin:0 0 1.25em 0;position:relative}.cnw_key_facts-widget:before{content:”;border-top:2px solid #008080;border-left:2px solid #008080;display:inline-block;width:12rem;height:3.25rem;position:absolute}.cnw_key_facts-widget:after{content:”;border-bottom:2px solid #008080;border-right:2px solid #008080;display:inline-block;width:12rem;height:3.25rem;position:absolute;bottom:0;right:0}.cnw_key_facts-widget .cnw_key_facts-header{text-transform:uppercase;letter-spacing: .05rem;font-family:Oxygen,Georgia,Arial;font-weight:bold;font-size:1rem;margin-bottom:0;display:block;padding:1.5625rem 1.25rem .5625rem}.cnw_key_facts-widget .cnw_key_facts-data{padding:0 1.25rem 1.25rem 1.25rem}@media screen and (max-width: 480px){.cnw_key_facts-widget:before{width:7rem;height:1.75rem}.cnw_key_facts-widget:after{width:7rem;height:1.75rem}.cnw_key_facts-widget .cnw_key_facts-header{padding:1rem 1rem 0.5rem 1rem}.cnw_key_facts-widget .cnw_key_facts-data{padding:0 0.5rem 1rem 0.5rem}.cnw_key_facts-widget .cnw_key_facts-data ul, .cnw_key_facts-widget .cnw_key_facts-data ol{margin-bottom:0 !important}.cnw_key_facts-widget .cnw_key_facts-data li:last-child{margin-bottom:0}} Key Facts Has sold 50 million albums worldwide Earns $20-40 million per year Raised over $1.5 million for COVID-19 charities Career: David first got started as a DJ after spinning tunes at the Broad Club in Paris. At first, he was simply playing popular songs for people to dance to. Eventually, he discovered house music and fell in love with this new music genre. Over the next period, Guetta started hosting his own club nights, collaborating with local hip-hop artists. In the mid-90s, David started to come out with his own singles. “Up & Away” became his first club hit, and in 1994 he became the manager of Le Palace nightclub. In 2001, David founded Gum Productions and came out with his first hit single “Just a Little More Love,” which featured Chris Willis. In 2002, Guetta released his debut album “Just a Little More Love” through Virgin Records. The album sold over 300,000 records and featured tracks like “Love Don’t Let Me Go” and “People Come People Go.” After gaining prominence for DJing in Ibiza, Guetta released his second album, “Guetta Blaster.” This album contained another collaboration with Chris Willis entitled “Stay.” In 2007, he released another album called “Pop Life,” which became successful throughout Europe. To date, the album has sold over 500,000 copies. “Love is Gone” was one track that made the album especially successful. By 2009, David Guetta was widely recognized as one of the best DJs on the planet. During this period, he started hosting his own radio show on the station RauteMusik. Although David was widely respected in the EDM community, it wasn’t until the 2010s that he started to break through on an international level. This coincided with the release of his fourth album, “One Love.” The track “When Love Takes Over” featured Kelly Rowland and topped the charts in many nations, including the United Kingdom. Another song entitled “Sexy Bitch” featured Akon and also topped the charts in the UK. More hits helped the album achieve triple platinum status worldwide. The album also received a Grammy nomination. Over the next few years, Guetta collaborated with Kelly Rowland, The Black Eyed Peas, Kelis Rogers, Flo Rida, and many others. This helped David reach higher levels of prominence, especially within the United States. In 2011, he released the album “Nothing but the Beat.” A documentary of the same name was later released that chronicled Guetta’s rise to fame. David then established a new record label called Jack Back Records. After touring with Rihanna, Guetta released the track “Shot Me Down” with singer Skylar Grey in 2014. After releasing his sixth album, “Listen,” Guetta acted as the official music ambassador for UEFA Euro 2016, and he created the official song for the tournament entitled “This One’s For You.” After further collaborations with artists like Lil Wayne and Nicki Minaj, Guetta headlined Tomorrowland. In 2018, he announced the upcoming release of his seventh album, “7.” He would later release a track from the album entitled “Don’t Leave Me Alone,” which featured British singer Anne-Marie. Relationships: David Guetta’s first wife was Cathy Lobé, a nightclub manager whom he wed in 1992. Over the course of their relationship, they had two children together before divorcing in 2014. They had spent over 22 years together as a married couple. Neither Guetta nor Lobé showed up to the divorce hearing, and the exact cause of their divorce was never revealed. Eventually, Lobé suggested that Guetta simply wanted a change. Real Estate: In 2012, it was confirmed that David Guetta had purchased a penthouse suite at Paraiso Bay in South Florida – a megaproject conducted by Related Group. Because he purchased the condo while the building was still being developed, he was able to create a custom-designed space made specifically for him. It was designed by a well-known Italian designer named Piero Lissoni, and it spans 2,387 square feet. Notable features include a floating staircase and floor-to-ceiling windows that provide panoramic views of Miami and the ocean. Even better, there’s a 2,121-square-foot rooftop terrace that includes a lounge, a bar, and a plunge pool. In 2018, it was announced that David was leasing this property out for $18,000 per month. In 2018, Guetta acquired a condo in Miami from a billionaire in New York. He paid $9.5 million for an apartment previously owned by Richard LeFrak, a real-estate magnate. Located on the 37th floor of the Setai Hotel & Residences building, the three-bedroom condo offers exceptional views of the Miami skyline and the ocean beyond. The building itself is quite luxurious, with three oceanfront swimming pools, a spa, immaculate gardens, and a gym. The 2,521-square-foot property only served as a vacation home for Guetta and he sought to rent it out when he wasn’t using it. Depending on the time of year, David demands rental fees of $10,000 to $28,000 per week, or $25,000 to $50,000 per month.
Read More